SCHEMBL8304875

SCHEMBL8304875

COc1cc2c(Nc3ccc(C(=O)c4ccccc4)c(Cl)c3)ncnc2cc1O

nearest known ligand 0.69

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 4/20 0.69
AURKA O14965 2/20 0.66
EGFR P00533 8/20 0.64
MAPK14 Q16539 5/20 0.64
KDR P35968 10/20 0.59
RET P07949 3/20 0.59
KIF5B P33176 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309364 0.93 EGFR (0.70) AURKBAURKAEGFRMAPK14KDR
Hydrochloric Acid SCHEMBL8307571 0.92 EGFR (0.69) AURKBAURKAEGFRMAPK14KDR
SCHEMBL8307965 0.89 EGFR (0.65) AURKBAURKAEGFRMAPK14KDR
SCHEMBL8309261 0.87 EGFR (0.64) AURKBAURKAEGFRMAPK14KDR
Hydrochloric Acid SCHEMBL8813291 0.85 KDR (0.67) AURKBAURKAEGFRMAPK14KDR
Hydrochloric Acid SCHEMBL8309441 0.84 EGFR (0.59) AURKBAURKAEGFRMAPK14KDR
SCHEMBL8306628 0.84 EGFR (0.66) AURKBAURKAEGFRKDRRET
SCHEMBL907182 0.83 KDR (0.77) AURKBAURKAEGFRKDRRET
SCHEMBL3531809 0.82 AURKB (1.00) AURKBAURKAEGFRMAPK14KDR
SCHEMBL8307434 0.82 EGFR (0.53) EGFRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed